Short Interest in TC Biopharm (Holdings) Plc (NASDAQ:TCBP) Rises By 293.3%

TC Biopharm (Holdings) Plc (NASDAQ:TCBP) was the recipient of a large increase in short interest in October. As of October 31st, there was short interest totalling 64,900 shares, an increase of 293.3% from the October 15th total of 16,500 shares. Based on an average daily volume of 698,100 shares, the short-interest ratio is presently 0.1 days.

TC Biopharm Price Performance

TCBP stock traded down $0.03 during mid-day trading on Wednesday, reaching $1.10. 51,138 shares of the company’s stock were exchanged, compared to its average volume of 373,566. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.88 and a current ratio of 0.88. The stock’s 50 day moving average is $4.47 and its 200 day moving average is $7.20. TC Biopharm has a 12-month low of $1.05 and a 12-month high of $138.00.

About TC Biopharm

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.